PLT concentrates with a new blood cell separator: results for a multicenter study. Transfusion 2003; 43:1107–1114.
44 44. Berger K, Schopohl D, Wittmann G, et al. Blood product supply in Germany: the impact of apheresis and pooled platelet concentrates. Transfus Med Hemother 2016; 43:389–394.
45 45. Surgenor DM, Wallace EL, Hao HS, Chapman RH. Collection and transfusion of blood in the United States, 1982–88. N Engl J Med 1990; 322:1646–1652.
46 46. The 2013 National Blood Collection and Utilization Survey Report, Department of Health and Human Services. Conducted under contract (HHSP23320110008TC) with the American Association of Blood Banks, and using OMB Number 0990–0313.
47 47. Gorlin JB, ed. Standards for Blood Banks and Transfusion Services, 26th edn. Bethesda, MD: American Association of Blood Banks, 2009.
48 48. Slichter SJ. Efficacy of platelets collected by semi‐continuous flow centrifugation (Haemonetics Model 30). Br J Haematol 1978; 38:131–140.
49 49. Katz A, Houx J, Ewald L. Storage of platelets prepared by discontinuous flow centrifugation. Transfusion 1978; 18:220–223.
50 50. Patel IP, Ambinder E, Holland JF, Aledort LM. In vitro and in vivo comparison of single‐donor platelets and multiple‐donor pooled platelets transfusions in leukemic patients. Transfusion 1978; 18:116–119.
51 51. Turner VS, Hawker RJ, Mitchell SG, Seymour Mead AM. Paired in vivo and in vitro comparison of apheresis and “recovered” platelet concentrates stored for five days. J Clin Apher 1994; 9:189–194.
52 52. Maguire LC, Henriksen RA, Strauss RG. Function and morphology of platelets produced for transfusion by intermittent‐flow centrifugation plateletpheresis or combined platelet‐leukapheresis. Transfusion 1981; 21:118–123.
53 53. Daly PA, Schiffer CA, Aisner J, Wiernik PH. A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis. Transfusion 1979; 19:778–781.
54 54. Rock GA, Blanchette VS, Wong SC. Storage of platelets collected by apheresis. Transfusion 1983; 23:99–105.
55 55. Meyer D, Bolgiano DC, Sayers M, et al. Red cell collection by apheresis technology. Transfusion 1993; 33:819–824.
56 56. Shi PA, Ness PM. Two‐unit red cell apheresis and its potential advantages over traditional whole‐blood donation. Transfusion 1999; 39:219–225.
57 57. Gilcher RO. It’s time to end RBC shortages. Transfusion 2003; 43:1658–1660.
58 58. Smith JW, Gilcher RO. Red blood cells, plasma, and other new apheresis‐derived blood products: improving product quality and donor utilization. Transfus Med Rev 1999; 13:118–123.
59 59. Holme S, Elfath MD, Whitley P. Evaluation of in vivo and in vitro quality of apheresis‐collected RBC stored for 42 days. Vox Sang 1998; 75:212–217.
60 60. Bandarenko N, Rose M, Kowalsky J, et al. In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in‐line WBC‐reduction filter. Transfusion 2001; 41:1373–1377.
61 61. Hogler W, Mayer W, Messmer C, et al. Prolonged iron depletion after allogeneic 2‐unit RBC apheresis. Transfusion 2001; 41:602–605.
62 62. Benjamin RJ, Ky BA, Kennedy JM, et al. The relative safety of automated two‐unit red blood cell procedures and manual whole‐blood collection in young donors. Transfusion 2009; 49:1874–1883.
63 63. Mishler JM, Hadlock DC, Fortuny IE, et al. Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge. Blood 1974; 44:571–581.
64 64. Mishler JM, Higby DJ, Rhomberg W. Hydroxyethyl starch and dexamethasone as an adjunct to leukocyte separation with the IBM blood cell separator. Transfusion 1974; 14:352–356.
65 65. Mishler JM, Hester JP, Heustis DW, et al. Dosage and scheduling regimens for erythrocyte‐sedimenting macromolecules. J Clin Apher 1983; 1:130–143.
66 66. Lee JH, Cullis H, Leitman SF, Klein HG. Efficacy of pentastarch in granulocyte collection by centrifugal leukapheresis. J Clin Apher 1995; 10:198–202.
67 67. Strauss RG. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low‐molecular‐weight hydroxyethyl starch. Vox Sang 1979; 37:268–271.
68 68. Ghodsi Z, Strauss RG. Cataracts in neutrophil donors stimulated with adrenal corticosteroids. Transfusion 2001; 41:1464–1468.
69 69. Burch JW, Mair DC, Meny GM, et al. The risk of posterior subcapsular cataracts in granulocyte donors. Transfusion 2005; 45:1701–1708.
70 70. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81:1883–1888.
71 71. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony‐stimulating factor. Blood 1993; 81:2866–2871.
72 72. Liles WC, Huang JE, Llewellyn C, et al. A comparative trial of granulocyte‐colony‐stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion 1997; 37:182–187.
73 73. Stroncek DF, Clay ME, Petzoldt ML, et al. Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996; 36:601–610.
74 74. Stroncek DF, Clay ME, Herr G, et al. The kinetics of G‐CSF mobilization of CD34+ cells in healthy people. Transfus Med 1997; 7:19–24.
75 75. Lightfoot T, Leitman SF, Stroncek DF. Storage of G‐CSF‐mobilized granulocyte concentrates. Transfusion 2000; 40:1104–1110.
76 76. Djerassi I, Kim JS, Suvansri U, et al. Continuous flow filtration—leukopheresis. Transfusion 1972; 12:75–83.
77 77. McCullough J, Weiblen BJ, Deinard AR, et al. In vitro function and post‐transfusion survival of granulocytes collected by continuous‐flow centrifugation and by filtration leukapheresis. Blood 1976; 48:315–326.
78 78. Wright DG, Kauffmann JC, Chusid MJ, et al. Functional abnormalities of human neutrophils collected by continuous flow filtration leukopheresis. Blood 1975; 46:901–911.
79 79. Schiffer CA, Aisner J, Wiernik PH. Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters. Blood 1975; 45:141–146.
80 80. Rubins JL, MacPherson JL, Nusbacher J, Wiltbank T. Granulocyte kinetics in donors undergoing filtration leukapheresis. Transfusion 1976; 16:56–62.
81 81. Hammerschmidt DE, Craddock PR, McCullough J, et al. Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis. Blood 1978; 51:721–730.
82 82. Nusbacher J, Rosenfeld SI, MacPherson JL, et al. Nylon fiber leukapheresis: associated complement component changes and granulocytopenia. Blood 1978; 51:359–365.
83 83. Wiltbank TB, Nusbacher J, Higby DJ, MacPherson JL. Abdominal pain in donors during filtration leukapheresis. Transfusion 1977; 17:159–162.
84 84. Glasser L, Huestis DW, Jones JF. Functional capabilities of steroid‐recruited neutrophils harvested for clinical transfusion. N Engl J Med 1977; 297:1033.
85 85. Glasser L. Functional considerations of granulocyte concentrates used for clinical transfusions. Transfusion 1979; 19:1.
86 86. Strauss RG, Maguire LC, Koepke JA, Thompson JS. Properties of neutrophils collected by discontinuous‐flow centrifugation leukapheresis employing hydroxyethyl starch. Transfusion 1979; 19:192.
87 87. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method, donor corticosteroid treatment, and short term storage. Blood 1979; 54:977.
88 88. McCullough J, Weiblen BJ, Fine D. Effects of